Fosanis collects millions

The provider is behind the Mika app, which is designed to provide cancer patients with digital support during treatment. IBB Ventures is now investing, among others.

The Berlin-based start-up Fosanis has closed another round of financing. The provider behind the Mika app is receiving money from Ananda Impact Ventures, IBB Ventures and the investment company Evodia, among others. Money has also flowed in from the ProFIT program of Investitionsbank Berlin.

According to the company, the money invested will go towards the distribution and expansion of its own app, as well as studies to show that the Mika app is effective. The aim is to be included in the list of digital health applications so that health insurance companies will cover the costs of digital therapy support. The Federal Institute for Drugs and Medical Devices is currently deciding on this.

Gandolf Finke and Jan Simon Raue founded Fosanis in 2017 and want to support people suffering from cancer with the Mika app. The app provides patients with useful information, tips and exercises to help them get through life despite cancer. The team is creating the content together with Charité Berlin, Leipzig University Hospital and the NCT (National Center for Tumor Diseases Heidelberg).

Gandolf Finke, Managing Director of Fosanis, says: "We are delighted that our investors are continuing to support the Mika app. It shows that we are on the right track. Our ultimate goal is to be the first leading prescription app for cancer patients in Germany."